Page last updated: 2024-11-04

temozolomide and Neoplasms, Bronchial

temozolomide has been researched along with Neoplasms, Bronchial in 4 studies

Research Excerpts

ExcerptRelevanceReference
"A retrospective analysis of the toxicity and efficacy of temozolomide in advanced neuroendocrine tumors."7.74Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors. ( Dunder, K; Ekeblad, S; Eriksson, B; Granberg, D; Janson, ET; Kindmark, H; Kozlovacki, G; Oberg, K; Orlefors, H; Sigurd, M; Skogseid, B; Sundin, A; Welin, S, 2007)
"A retrospective analysis of the toxicity and efficacy of temozolomide in advanced neuroendocrine tumors."3.74Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors. ( Dunder, K; Ekeblad, S; Eriksson, B; Granberg, D; Janson, ET; Kindmark, H; Kozlovacki, G; Oberg, K; Orlefors, H; Sigurd, M; Skogseid, B; Sundin, A; Welin, S, 2007)
"Everolimus is an appropriate first-line choice for somatostatin receptor negative tumors and for any patients with progressive disease."2.66Pulmonary Neuroendocrine Tumors: Adjuvant and Systemic Treatments. ( Halfdanarson, TR; Leventakos, K; Molina, JR; Uprety, D, 2020)
"Temozolomide was given on 5 consecutive days every 4 weeks."1.39Effect of temozolomide in patients with metastatic bronchial carcinoids. ( Antonodimitrakis, P; Crona, J; Eriksson, B; Fanola, I; Granberg, D; Lindholm, DP; Öberg, K, 2013)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Uprety, D1
Halfdanarson, TR1
Molina, JR1
Leventakos, K1
Crona, J1
Fanola, I1
Lindholm, DP1
Antonodimitrakis, P1
Öberg, K2
Eriksson, B2
Granberg, D2
Pregun, I1
Bodoky, G1
Rácz, K1
Tulassay, Z1
Ekeblad, S1
Sundin, A1
Janson, ET1
Welin, S1
Kindmark, H1
Dunder, K1
Kozlovacki, G1
Orlefors, H1
Sigurd, M1
Skogseid, B1

Reviews

2 reviews available for temozolomide and Neoplasms, Bronchial

ArticleYear
Pulmonary Neuroendocrine Tumors: Adjuvant and Systemic Treatments.
    Current treatment options in oncology, 2020, 08-29, Volume: 21, Issue:11

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Capecita

2020
[Carcinoid tumors].
    Orvosi hetilap, 2010, Nov-14, Volume: 151, Issue:46

    Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Biomarkers, Tumor; Bronchial Neoplasms; Carcinoid Tumo

2010

Other Studies

2 other studies available for temozolomide and Neoplasms, Bronchial

ArticleYear
Effect of temozolomide in patients with metastatic bronchial carcinoids.
    Neuroendocrinology, 2013, Volume: 98, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Bronchial Neoplasms; Carcinoid Tu

2013
Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2007, May-15, Volume: 13, Issue:10

    Topics: Aged; Bronchial Neoplasms; Carcinoid Tumor; Dacarbazine; Female; Hematologic Diseases; Humans; Male;

2007